Results 171 to 180 of about 39,266 (270)

Cryptococcid Sweet Syndrome in the Setting of Hydralazine‐Induced ANCA Vasculitis: A Case Report

Journal of Cutaneous Pathology, Volume 53, Issue 4, Page 356-361, April 2026.
ABSTRACT Acute febrile neutrophilic dermatosis, also known as Sweet syndrome, is an inflammatory skin condition characterized by the rapid onset of painful, erythematous plaques or nodules with neutrophilic infiltrate on histology. Rarely, acellular bodies surrounded by vacuolated spaces have been noted within the neutrophilic infiltrate, mimicking ...
Jenna Vroman, Pelin Sagut, Kathryn Lynam, Amanda Ederle, Laura Winterfield   +4 more
wiley   +1 more source

Safety profile of vunakizumab in elderly patients with moderate-to-severe plaque psoriasis: a post-hoc analysis. [PDF]

Front Med (Lausanne)
Mu T, He Y, Zhang M, Wang C, Zhai Z, Song Z.   +5 more
europepmc   +1 more source

Molecular Markers Distinguishing Early‐Stage Mycosis Fungoides From Atopic Dermatitis Skin Lesions

Experimental Dermatology, Volume 35, Issue 4, April 2026.
ABSTRACT Mycosis fungoides (MF) is the most common type of primary cutaneous T‐cell lymphoma, a disease characterized by malignant T cells that home to the skin. In early stages, clinical presentation is often indistinguishable from benign chronic inflammatory skin diseases such as atopic dermatitis (AD), posing a challenge for proper diagnosis and ...
Brandon D. Ng, Conor Whelan, Natalia Alkon, Agata Kurowski, Constanze Jonak, Patrick M. Brunner   +5 more
wiley   +1 more source

A Comparative Study of Oral Tofacitinib and Oral Methotrexate in the Treatment of Patients With Moderate to Severe Chronic Plaque Psoriasis. [PDF]

Cureus
Unnikrishnan P, Vudayana K, Chintada D, Khatija Begum M, Chalamalasetty SS, Gullipalli P.   +5 more
europepmc   +1 more source

Safety and efficacy of oral icotrokinra for moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Front Immunol
AlJuma RS, Hashim S, Alshamali MA, Alkhatlan S, Hammadi DJ, Alharran AM.   +5 more
europepmc   +1 more source

Biosimilars for the Treatment of Moderate to Severe Chronic Plaque Psoriasis. [PDF]

Psoriasis (Auckl)
Gisondi P, Bellinato F, Curic T, Girolomoni G.   +3 more
europepmc   +1 more source

Methotrexate-induced cutaneous ulceration in 3 nonpsoriatic patients: Report of a rare side effect [PDF]

, 2017
Chibnall, Rebecca J, Lewis, Hal A, Musiek, Amy C, Nemer, Kathleen M   +3 more
core   +2 more sources

Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis. [PDF]

Dermatol Ther (Heidelb)
Armstrong AW, Warren RB, Sofen H, Spelman L, Linaberry M, Becker B, Jou YM, Daamen C, Kimball AB.   +8 more
europepmc   +1 more source

Efficacy of secukinumab in pediatric patients with moderate to severe plaque psoriasis: A randomized study. [PDF]

Medicine (Baltimore)
Zhang Y, Lu X, Zhou Y, Lei L, Wang L, Liang N, Li C.   +6 more
europepmc   +1 more source

Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study. [PDF]

Dermatol Ther (Heidelb)
Torres T, Sood S, Yilmaz O, Vender RB, Prajapati VH, Puig L, Megna M, Marzano AV, Gisondi P, Carrascosa JM, Dauden E, Llamas-Velasco M, Balato A, Leal BG, Prignano F, Bellinato F, Silvi G, Di Brizzi EV, Potestio L, Carrera CG, López-Ferrer A, Del-Alcazar E, Mufti A, Maul LV, Piaserico S, Maul JT, Yeung J.   +26 more
europepmc   +1 more source